Shares of Healthequity Inc (NASDAQ:HQY) have been assigned an average rating of “Buy” from the twelve brokerages that are presently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $57.50.
HQY has been the topic of several research reports. Cantor Fitzgerald reiterated a “buy” rating and issued a $60.00 price target on shares of Healthequity in a research report on Thursday, February 22nd. BidaskClub upgraded shares of Healthequity from a “hold” rating to a “buy” rating in a research report on Friday, February 16th. Zacks Investment Research upgraded shares of Healthequity from a “hold” rating to a “buy” rating and set a $57.00 price target on the stock in a research report on Saturday, February 10th. Citigroup initiated coverage on shares of Healthequity in a research report on Thursday, January 4th. They issued a “buy” rating on the stock. Finally, Chardan Capital increased their price target on shares of Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a research report on Wednesday, December 6th.
Shares of Healthequity (NASDAQ:HQY) opened at $58.87 on Wednesday. The company has a market cap of $3,590.60, a P/E ratio of 84.54, a PEG ratio of 2.26 and a beta of 1.46. Healthequity has a 1 year low of $37.62 and a 1 year high of $59.99.
Several institutional investors and hedge funds have recently made changes to their positions in the stock. Carillon Tower Advisers Inc. purchased a new position in Healthequity during the fourth quarter worth approximately $34,100,000. Eagle Asset Management Inc. purchased a new position in Healthequity during the third quarter worth approximately $36,875,000. Victory Capital Management Inc. raised its stake in Healthequity by 116.4% during the fourth quarter. Victory Capital Management Inc. now owns 1,031,711 shares of the company’s stock worth $48,139,000 after purchasing an additional 555,027 shares during the period. Wells Fargo & Company MN raised its stake in Healthequity by 49.5% during the third quarter. Wells Fargo & Company MN now owns 1,108,410 shares of the company’s stock worth $56,063,000 after purchasing an additional 366,925 shares during the period. Finally, BlackRock Inc. raised its stake in Healthequity by 3.8% during the fourth quarter. BlackRock Inc. now owns 6,751,491 shares of the company’s stock worth $315,026,000 after purchasing an additional 244,819 shares during the period. 99.63% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION NOTICE: “Healthequity Inc (HQY) Given Consensus Recommendation of “Buy” by Brokerages” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/3261002/healthequity-inc-hqy-given-consensus-recommendation-of-buy-by-brokerages.html.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.